World's Best Scientists 2026 revealed!

Morris Reichlin publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Morris Reichlin sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

The last bar groups every scientist with 807 publications or more.

Morris Reichlin D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Morris Reichlin sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

The last bar groups every scientist with 157 D-Index or more.

Overview

Morris Reichlin was affiliated with the Oklahoma Medical Research Foundation in the United States. Their career was connected to this institution, contributing to the scientific community through research activities conducted there.

There are no records available of recent papers authored or co-authored by Morris Reichlin, nor are there listed frequent co-authors or publication venues associated with their work. Similarly, no information about book publications or specific fields and subfields of study is documented in the available data.

No particular main topics of work or research themes have been identified or listed in the source data. Additionally, there are no awards recorded as having been received by Morris Reichlin. The absence of these details suggests limited available public data on the scope or impact of their research output.

This profile reflects available verifiable information as per academic and bibliometric sources, presenting a factual overview without extrapolation beyond the data supplied.

Best Publications

  • THE ANTIGENIC STRUCTURE OF PROTEINS: A REAPPRAISAL

    D C Benjamin;J A Berzofsky;I J East;F R Gurd

  • Autoimmune-Associated Congenital Heart Block: Demographics, Mortality, Morbidity and Recurrence Rates Obtained From a National Neonatal Lupus Registry ☆

    Jill P. Buyon;Rudi Hiebert;Joshua Copel;Joseph Craft

  • Serologic and HLA Associations in Subacute Cutaneous Lupus Erythematosus, a Clinical Subset of Lupus Erythematosus

    Richard D. Sontheimer;Peter J. Maddison;Morris Reichlin;Robert E. Jordon

  • Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis

    Masahiko Nishikai;Morris Reichlin

  • Factors predictive of outcome in severe lupus nephritis

    Stephen M. Korbet;Edmund J. Lewis;Melvin M. Schwartz;Morris Reichlin

  • Serological findings in patients with "ANA-negative" systemic lupus erythematosus.

    Peter J. Maddison;Thomas T. Provost;Morris Reichlin

  • Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome.

    John B. Harley;Elaine L. Alexander;Wilma B. Bias;Owen F. Fox

  • Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigen.

    Martha Mattioli;Morris Reichlin

  • Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome

    John B. Harley;Morris Reichlin;Frank C. Arnett;Elaine L. Alexander

  • The association between Mi-2 antibodies and dermatomyositis

    Ira N. Targoff;Morris Reichlin

  • Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000; pI, 8.5) rich in NG,NG-dimethylarginine.

    M A Lischwe;R L Ochs;R Reddy;R G Cook

  • [8] Use of glutaraldehyde as a coupling agent for proteins and peptides

    Unknown

  • ANTI-DNA ANTIBODY IDIOTYPES IN SYSTEMIC LUPUS ERYTHEMATOSUS

    David A. Isenberg;Michael P. Madaio;Morris Reichlin;Yehuda Shoenfeld

  • Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis

    Christopher C. Najafi;Christopher C. Najafi;Stephen M. Korbet;Stephen M. Korbet;Edmund J. Lewis;Edmund J. Lewis;Melvin M. Schwartz;Melvin M. Schwartz

  • Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody.

    Robert G. Hamilton;John B. Harley;John B. Harley;Wilma B. Bias;Wilma B. Bias;Marianne Roebber

  • Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells.

    E Koren;M W Reichlin;M Koscec;R D Fugate

  • Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system.

    Aviva Katzav;Inna Solodeev;Ori Brodsky;Joab Chapman

  • Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes

    M. Reichlin;P. J. Maddison;I. Targoff;Thomas Bunch

  • Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities.

    Vincent Falanga;Thomas A. Medsger;Morris Reichlin;Gerald P. Rodnan

  • Correlation of a precipitin reaction to an RNAprotein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus.

    Morris Reichlin;Martha Mattioli

  • Amino Acid Substitution and the Antigenicity of Globular Proteins

    Morris Reichlin

Frequent Co-Authors

John B. Harley
John B. Harley United States Department of Veterans Affairs
Judith A. James
Judith A. James Oklahoma Medical Research Foundation
Ira N. Targoff
Ira N. Targoff University of Oklahoma Health Sciences Center
R. Hal Scofield
R. Hal Scofield University of Oklahoma Health Sciences Center
Yehuda Shoenfeld
Yehuda Shoenfeld Sheba Medical Center
Miri Blank
Miri Blank Tel Aviv University
Jennifer A. Kelly
Jennifer A. Kelly Oklahoma Medical Research Foundation
Wei Zhang
Wei Zhang Central South University
Joab Chapman
Joab Chapman Tel Aviv University
Jill P. Buyon
Jill P. Buyon New York University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in combining immunology with advanced nursing roles, exploring pmhnp programs online with best clinical placement can provide valuable pathways. These programs focus on psychiatric mental health nurse practitioner training, often offering strong clinical experiences that complement immunological knowledge in patient care.

Cost is a major consideration for many students. Finding cheapest psychiatric nurse practitioner programs allows aspiring healthcare professionals to pursue specialized degrees without overwhelming financial burden, which is crucial when investing in a career that intersects nursing and immunology.

Understanding earning potential is equally important. Those pursuing a Doctor of Nursing Practice (DNP) should research how much does a dnp make to evaluate the return on their educational investment. Salaries can vary significantly by state, affecting career decisions and relocation considerations.

Many nurses aim to shift their focus to more acute care settings. Guidance on making this switch is available, such as strategies for fnp to acnp transitions. This pathway can expand career opportunities by combining immunology expertise with advanced clinical practice in acute care.

Best Scientists Citing Morris Reichlin

Recently Published Articles